Global Trigeminal Neuralgia Therapeutics Market by Product (Drug, Surgery), End-user (Ambulatory Surgery Centers, Hospital & Clinics) - Forecast 2024-2030- Product Image

Sale

Global Trigeminal Neuralgia Therapeutics Market by Product (Drug, Surgery), End-user (Ambulatory Surgery Centers, Hospital & Clinics) - Forecast 2024-2030

Report
196 Pages
March 2024
Region: Global
360iResearch™
ID: 5367904

UP TO €851EUR$875USD£729GBP OFF until Dec 31^st 2024

The Trigeminal Neuralgia Therapeutics Market size was estimated at USD 242.95 million in 2023, USD 262.17 million in 2024, and is expected to grow at a CAGR of 8.00% to reach USD 416.55 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Trigeminal Neuralgia Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Trigeminal Neuralgia Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Trigeminal Neuralgia Therapeutics Market, highlighting leading vendors and their innovative profiles. These include AMBOSS GmbH, Biogen, Inc., Cadila Pharmaceuticals Limited, Capnia, Inc., Cephalon A/S, Danaher Corporation, Glenmark Pharmaceuticals Limited, GSK plc, H. Lundbeck A/S, Johnson & Johnson Services, Inc., LGM Pharma, LLC, Lupin Limited, Novartis AG, and Pfizer Inc.

Market Segmentation & Coverage

This research report categorizes the Trigeminal Neuralgia Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Drug
  - Anticonvulsant Medicines
  - Tricyclic Antidepressants
- Surgery
  - Microvascular Decompression
  - Radiofrequency Thermal Lesioning
  - Stereotactic Radiosurgery
End-user
- Ambulatory Surgery Centers
- Hospital & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Trigeminal Neuralgia Therapeutics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Trigeminal Neuralgia Therapeutics Market?
What are the technology trends and regulatory frameworks in the Trigeminal Neuralgia Therapeutics Market?
What is the market share of the leading vendors in the Trigeminal Neuralgia Therapeutics Market?
Which modes and strategic moves are suitable for entering the Trigeminal Neuralgia Therapeutics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Trigeminal Neuralgia Therapeutics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of neuralgia due to the rise in the aging population
5.1.1.2. Government initiatives to spread awareness regarding neuralgia treatment products
5.1.2. Restraints
5.1.2.1. High-cost associated with the treatment of neuralgia
5.1.3. Opportunities
5.1.3.1. Technological advancement eliminates the need for drugs and surgery
5.1.3.2. Developing surgical and pharmacological treatment in developing economies
5.1.4. Challenges
5.1.4.1. Persistent side effects from medications
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Trigeminal Neuralgia Therapeutics Market, by Product

6.1. Introduction
6.2. Drug
6.3.1. Anticonvulsant Medicines
6.3.2. Tricyclic Antidepressants
6.3. Surgery
6.4.1. Microvascular Decompression
6.4.2. Radiofrequency Thermal Lesioning
6.4.3. Stereotactic Radiosurgery

7. Trigeminal Neuralgia Therapeutics Market, by End-user

7.1. Introduction
7.2. Ambulatory Surgery Centers
7.3. Hospital & Clinics

8. Americas Trigeminal Neuralgia Therapeutics Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Trigeminal Neuralgia Therapeutics Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Trigeminal Neuralgia Therapeutics Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. AMBOSS GmbH
12.1.2. Biogen, Inc.
12.1.3. Cadila Pharmaceuticals Limited
12.1.4. Capnia, Inc.
12.1.5. Cephalon A/S
12.1.6. Danaher Corporation
12.1.7. Glenmark Pharmaceuticals Limited
12.1.8. GSK plc
12.1.9. H. Lundbeck A/S
12.1.10. Johnson & Johnson Services, Inc.
12.1.11. LGM Pharma, LLC
12.1.12. Lupin Limited
12.1.13. Novartis AG
12.1.14. Pfizer Inc.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET DYNAMICS
FIGURE 7. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 10. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 8. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY ANTICONVULSANT MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 12. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY RADIOFREQUENCY THERMAL LESIONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 33. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 34. CANADA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 37. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 38. MEXICO TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. CHINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. CHINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 55. CHINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 56. CHINA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. INDIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. INDIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 59. INDIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 60. INDIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. JAPAN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. JAPAN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 67. JAPAN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 68. JAPAN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. PHILIPPINES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. SINGAPORE TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. SOUTH KOREA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. TAIWAN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. THAILAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. THAILAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 91. THAILAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 92. THAILAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. VIETNAM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. DENMARK TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. DENMARK TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 104. DENMARK TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. EGYPT TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. EGYPT TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 108. EGYPT TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 109. EGYPT TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. FINLAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. FINLAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 112. FINLAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 113. FINLAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. FRANCE TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. FRANCE TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 116. FRANCE TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 117. FRANCE TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. GERMANY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. GERMANY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 120. GERMANY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 121. GERMANY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. ITALY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. ITALY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 128. ITALY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 129. ITALY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. NETHERLANDS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NORWAY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NORWAY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 140. NORWAY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 141. NORWAY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. POLAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. POLAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 144. POLAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 145. POLAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. QATAR TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. QATAR TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 148. QATAR TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 149. QATAR TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SPAIN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SPAIN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 164. SPAIN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 165. SPAIN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SWEDEN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. TURKEY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. TURKEY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 176. TURKEY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 177. TURKEY TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 187. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 188. TRIGEMINAL NEURALGIA THERAPEUTICS MARKET LICENSE & PRICING

Companies Mentioned

AMBOSS GmbH
Biogen, Inc.
Cadila Pharmaceuticals Limited
Capnia, Inc.
Cephalon A/S
Danaher Corporation
Glenmark Pharmaceuticals Limited
GSK plc
H. Lundbeck A/S
Johnson & Johnson Services, Inc.
LGM Pharma, LLC
Lupin Limited
Novartis AG
Pfizer Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	196
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 262.17 Million
Forecasted Market Value ( USD ) by 2030	$ 416.55 Million
Compound Annual Growth Rate	8.0%
Regions Covered	Global
No. of Companies Mentioned	14

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3283EUR$3,374USD£2,812GBP €3648EUR$3,749USD£3,125GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4159EUR$4,274USD£3,562GBP €4621EUR$4,749USD£3,958GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5034EUR$5,174USD£4,313GBP €5594EUR$5,749USD£4,792GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5910EUR$6,074USD£5,063GBP €6567EUR$6,749USD£5,625GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7661EUR$7,874USD£6,563GBP €8513EUR$8,749USD£7,292GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Trigeminal Neuralgia Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

Trigeminal Neuralgia - Pipeline Insight, 2024

Neuralgia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

Neuralgia Treatment Global Market Report 2024